IS2725B - Inndælingarlausn sem samanstendur af LHRH mótlyfi - Google Patents

Inndælingarlausn sem samanstendur af LHRH mótlyfi

Info

Publication number
IS2725B
IS2725B IS7251A IS7251A IS2725B IS 2725 B IS2725 B IS 2725B IS 7251 A IS7251 A IS 7251A IS 7251 A IS7251 A IS 7251A IS 2725 B IS2725 B IS 2725B
Authority
IS
Iceland
Prior art keywords
solution consisting
injection solution
lhrh antagonist
lhrh
antagonist
Prior art date
Application number
IS7251A
Other languages
English (en)
Other versions
IS7251A (is
Inventor
Werner Sarlikiotis
Horst Bauer
Matthias Rischer
Juergen Engel
Frank Guthlein
Dominique Di Stefano
Original Assignee
Zentaris Ivf Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ivf Gmbh filed Critical Zentaris Ivf Gmbh
Publication of IS7251A publication Critical patent/IS7251A/is
Publication of IS2725B publication Critical patent/IS2725B/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7251A 2001-11-26 2004-05-06 Inndælingarlausn sem samanstendur af LHRH mótlyfi IS2725B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10157628A DE10157628A1 (de) 2001-11-26 2001-11-26 Injektionslösung eines LHRH-Antagonisten
PCT/EP2002/012798 WO2003045419A1 (de) 2001-11-26 2002-11-15 Injektionslösung eines lhrh-antagonisten

Publications (2)

Publication Number Publication Date
IS7251A IS7251A (is) 2004-05-06
IS2725B true IS2725B (is) 2011-03-15

Family

ID=7706799

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7251A IS2725B (is) 2001-11-26 2004-05-06 Inndælingarlausn sem samanstendur af LHRH mótlyfi

Country Status (33)

Country Link
EP (1) EP1448221B1 (is)
JP (1) JP4343693B2 (is)
KR (1) KR100936636B1 (is)
CN (1) CN100404068C (is)
AR (1) AR037424A1 (is)
AT (1) ATE350050T1 (is)
AU (1) AU2002365504B2 (is)
BR (1) BRPI0214412B8 (is)
CO (1) CO5580793A2 (is)
CY (1) CY1106401T1 (is)
DE (2) DE10157628A1 (is)
DK (1) DK1448221T3 (is)
EA (1) EA010787B1 (is)
ES (1) ES2276970T3 (is)
GE (1) GEP20063861B (is)
HK (1) HK1073078A1 (is)
HR (1) HRP20040587B1 (is)
HU (1) HU230992B1 (is)
IL (2) IL161894A0 (is)
IS (1) IS2725B (is)
ME (1) ME00499B (is)
MX (1) MXPA04005018A (is)
NO (1) NO333364B1 (is)
NZ (1) NZ533712A (is)
PL (1) PL206199B1 (is)
PT (1) PT1448221E (is)
RS (1) RS51408B (is)
RU (1) RU2322969C2 (is)
SI (1) SI1448221T1 (is)
TW (1) TWI312283B (is)
UA (1) UA81612C2 (is)
WO (1) WO2003045419A1 (is)
ZA (1) ZA200404051B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
BRPI0710503A2 (pt) 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
US8999383B2 (en) * 2008-05-07 2015-04-07 Merrion Research Iii Limited Compositions of GnRH related compounds and processes of preparation
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
BR112013017169A2 (pt) 2011-01-07 2016-10-04 Merrion Res Iii Ltd composições farmacêuticas de ferro para administração oral
CN103690560B (zh) * 2013-12-17 2016-08-17 辽宁海思科制药有限公司 一种转化糖电解质注射液药物组合物及其制备方法
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
RU2614234C2 (ru) * 2015-03-31 2017-03-23 Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) Фармацевтическая композиция на основе 3-(4-Метилимидазол-1-ил)имидазо[1,2-b][1,2,4,5]тетразина в качестве противоопухолевого средства
KR20210157482A (ko) * 2017-01-30 2021-12-28 안테브 리미티드 적어도 하나의 gnrh 길항제를 포함하는 조성물
HRP20211890T1 (hr) 2019-10-24 2022-03-04 Sun Pharmaceutical Industries Ltd Stabilan parenteralni dozni oblik cetroreliks acetata

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
TR200200738T2 (tr) * 1999-09-23 2002-08-21 Zentaris Ag Endometriyal dokunun rahim dışında çoğalması, kronik alt karın ağrısı ve fallop tüpü tıkanıklığının terapötik olarak giderilmesi.
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung

Also Published As

Publication number Publication date
EP1448221A1 (de) 2004-08-25
HRP20040587B1 (en) 2008-01-31
ZA200404051B (en) 2005-05-25
PL369548A1 (en) 2005-05-02
RS51408B (sr) 2011-02-28
CN1592630A (zh) 2005-03-09
NO333364B1 (no) 2013-05-13
CO5580793A2 (es) 2005-11-30
RS44904A (en) 2006-10-27
DE50209193D1 (de) 2007-02-15
TW200300352A (en) 2003-06-01
AR037424A1 (es) 2004-11-10
AU2002365504A1 (en) 2003-06-10
DK1448221T3 (da) 2007-03-19
TWI312283B (en) 2009-07-21
MXPA04005018A (es) 2004-08-11
HK1073078A1 (en) 2005-09-23
PL206199B1 (pl) 2010-07-30
HUP0401986A2 (hu) 2005-01-28
PT1448221E (pt) 2007-03-30
RU2004119821A (ru) 2005-04-20
KR100936636B1 (ko) 2010-01-14
BR0214412A (pt) 2004-09-14
ATE350050T1 (de) 2007-01-15
GEP20063861B (en) 2006-06-26
DE10157628A1 (de) 2003-06-12
HRP20040587A2 (en) 2004-10-31
CN100404068C (zh) 2008-07-23
IL161894A (en) 2014-05-28
HU230992B1 (hu) 2019-08-28
NZ533712A (en) 2006-01-27
IS7251A (is) 2004-05-06
EP1448221B1 (de) 2007-01-03
BRPI0214412B1 (pt) 2016-01-05
EA010787B1 (ru) 2008-10-30
JP4343693B2 (ja) 2009-10-14
AU2002365504B2 (en) 2007-06-28
ME00499B (me) 2011-10-10
WO2003045419A1 (de) 2003-06-05
RU2322969C2 (ru) 2008-04-27
IL161894A0 (en) 2005-11-20
UA81612C2 (ru) 2008-01-25
KR20040058312A (ko) 2004-07-03
CY1106401T1 (el) 2011-10-12
NO20042449L (no) 2004-06-11
JP2005510544A (ja) 2005-04-21
ES2276970T3 (es) 2007-07-01
SI1448221T1 (sl) 2007-06-30
EA200400742A1 (ru) 2004-12-30
HUP0401986A3 (en) 2012-09-28
BRPI0214412B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
IS6886A (is) Kínasólín sem MMP-13 hindrar
DK1307181T3 (da) Hidtil ukendte sammensætninger af minoxidil
DE60229906D1 (de) Multiplex Einspritzdüse
IS7328A (is) Útskiptar kínasólínafleiður sem hemlar gegn árórakínösum
DK1438306T3 (da) Derivater af UK-2A
NO20024508D0 (no) Bygningskomponenter av kompositt
PT1263490E (pt) Injector sem agulha miniaturizado
DE50112588D1 (de) Einspritzdüse
HK1073078A1 (en) Injection solution comprising an lhrh antagonist
DE50207930D1 (de) Sicherungsbauelement
ATE374183T1 (de) Nk1-antagonisten
IS7159A (is) Ný imídasópýridínefnasambönd sem hafa meðferðarfræðileg áhrif
NO20035713L (no) Forbindelsesforankring
DE60122834D1 (de) Torsions-Kipp-Komponente
DE50107401D1 (de) Einspritzdüse
IS6620A (is) Nýr fjölgervingur V af tórasemíði
DK1309607T3 (da) Fremgangsmåde til fremstilling af LHRH-antagonister
FI20011778A0 (fi) Ryhmälähetyksen toteutus
DE50105875D1 (de) Bauteil
DE10111783B4 (de) Einspritzdüse
DE10294532D2 (de) Künstlicher Lymphknoten
DE50103123D1 (de) Halbleiter-bauelement
DE60227314D1 (de) Komparatorschaltung
DE50107699D1 (de) Bauelement
DE60131852D1 (de) Sprühgerät